The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential - Scorecard - MDSpire

The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential

  • By

  • Yaqing Yao

  • Sijia Li

  • Shuangshuang Wang

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Investigating Sortilin's Involvement in Cardiovascular Calcification: Mechanisms and Therapeutic Implications

At a Glance

CategoryDetail
ConditionCardiovascular calcification
Key MechanismsInvolves osteogenic differentiation, inflammation, and metabolic disturbances; sortilin links metabolic risk factors to pro-calcific responses.
Target PopulationPatients with diabetes, atherosclerosis, chronic kidney disease, and hypertension.
Care SettingClinical and research settings focused on cardiovascular health.

Key Highlights

  • Sortilin is a critical molecular mediator in cardiovascular calcification.
  • Elevated sortilin levels are linked to hypertension and cardiovascular risk.
  • Sortilin integrates multiple risk factors into pro-calcific cellular responses.
  • No pharmacological therapy currently halts or reverses cardiovascular calcification.
  • Sortilin may serve as a biomarker and therapeutic target for cardiovascular calcification.

Guideline-Based Recommendations

Diagnosis

  • Consider sortilin levels as a potential biomarker for cardiovascular risk assessment.

Management

  • Investigate targeting sortilin pathways for therapeutic strategies in cardiovascular calcification.

Monitoring & Follow-up

  • Monitor sortilin levels in patients with hypertension and dyslipidemia.

Risks

  • Recognize the role of sortilin in the progression of cardiovascular calcification linked to metabolic disorders.

Patient & Prescribing Data

Individuals with cardiovascular risk factors such as CKD, diabetes, and hypertension.

Current therapies do not reverse calcification; sortilin-targeted approaches are under investigation.

Clinical Best Practices

  • Assess sortilin levels in patients with cardiovascular risk factors.
  • Integrate management of dyslipidemia and hypertension to mitigate calcification risk.
  • Conduct further research on sortilin's role in cardiovascular health.

Related Resources & Content

Original Source(s)

Related Content